CIK 0001818794
- Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364883909
- Phone
- +1 781-786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Medical Officer sold 5,617 shares at $8.56 ($48,082)
- 4 Grant or award See Remarks acquired 16,696 shares (grant or award)
- 4 Grant or award See Remarks acquired 25,311 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 40,315 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 22,307 shares (grant or award)
- 4 Grant or award See Remarks acquired 118,190 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 36,524 shares (grant or award)
- 4 Gift See Remarks gave 3,500 shares (gift)
- 4 Open-market sale Chief Operating Officer sold 2,451 shares at $17.22 ($42,206)
- 4 Open-market sale See Remarks sold 859 shares at an average $15.90 ($13,655)
- 4 Open-market sale See Remarks sold 1,274 shares at an average $15.90 ($20,252)
- 4 Open-market sale See Remarks sold 8,009 shares at an average $15.90 ($127,312)
- 4 Open-market sale Chief Scientific Officer sold 1,444 shares at an average $15.90 ($22,954)
- 4 Other disposition 10% owner disposed of 814,013 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 16 of 19 · 365 filings